Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zi-Yan Yang
An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway
Biology Open
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
Related publications
AKT Signaling in ERBB2-amplified Breast Cancer
Pharmacology and Therapeutics
Pharmacology
Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
B7-H3 Induces Ovarian Cancer Drugs Resistance Through an PI3K/AKT/BCL-2 Signaling Pathway
Cancer Management and Research
Oncology
Pristimerin Overcomes Adriamycin Resistance in Breast Cancer Cells Through Suppressing Akt Signaling
Oncology Letters
Cancer Research
Oncology
Targeted Lapatinib Anti-Her2/ErbB2 Therapy Resistance in Breast Cancer: Opportunities to Overcome a Difficult Problem
Loss of Nrdp1 Enhances ErbB2/ErbB3-Dependent Breast Tumor Cell Growth
Cancer Research
Cancer Research
Oncology
Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Inhibition of Esophageal Cancer Growth Through the Suppression of PI3K/AKT/mTOR Signaling Pathway
OncoTargets and Therapy
Oncology
Pharmacology
PTBP1 Promotes the Growth of Breast Cancer Cells Through the PTEN/Akt Pathway and Autophagy
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
